U.S Appeals Court Lifts Injunction Against Hanmi’s Modified Nexium Generic – AstraZeneca
This article was originally published in PharmAsia News
Executive Summary
U.K. drug maker AstraZeneca said a U.S. federal appeals court has lifted an injunction against Hanmi Pharmaceutical Co. Ltd. launching Esomezol, an incrementally modified generic of its blockbuster Nexium (esomeprazole).